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Introduction: Sepsis-induced myopathy and critical illness myopathy (CIM) are possible causes of muscle weakness
in intensive care patients. They have been attributed to muscle membrane dysfunction. The aim of this study was
to investigate membrane properties in the early stage of experimental sepsis by evaluating muscle excitability.
Methods: In total, 20 anaesthetized and mechanically ventilated pigs were randomized to either faecal peritonitis
(n = 10) or to non-septic controls (n = 10). Resuscitation with fluids and vasoactive drugs was started 3 hours after
peritonitis induction. Muscle membrane properties were investigated by measuring muscle velocity recovery cycles
before induction of peritonitis as well as 6, 18 and 27 hours thereafter. Muscle relative refractory period (MRRP) and
early supernormality (ESN) were assessed.
Results: Peritonitis lasting 27 hours was associated with an increase of MRRP by 28% from 2.38 ± 0.18 ms (mean ± SD)
to 3.47 ± 1.79 ms (P <0.01) and a decrease of ESN by 31% from 9.64 ± 2.82% to 6.50 ± 2.64% (P <0.01). ESN reduction
was already apparent 6 hours after induction of peritonitis. Values in controls did not show any significant alterations.
Conclusions: Muscle membrane abnormalities consistent with membrane depolarization and/or sodium channel
inactivation occurred within 6 hours of peritonitis induction. This indicates that changes that have been described in
established sepsis-induced myopathy and/or CIM start early in the course of sepsis. Muscle excitability testing facilitates
evaluation of the time course of these changes.Introduction
Intensive care unit (ICU)-acquired weakness is a frequent
and severe complication in ICU patients. Typically, these
patients develop diffuse muscle weakness and failure to
wean from mechanical ventilation. The entities that
variably contribute to ICU-acquired weakness are critical
illness polyneuropathy (CIP) and myopathy (CIM) and/or
sepsis-induced myopathy [1-3]. Muscle pathologies seem
to be much more heterogeneous than CIP and may occur
independently of, or in association with, CIP [1-5].
Whereas structural changes have been reported for both
[1,2], the pathogenesis of these entities is still a matter of
debate. Impaired microcirculation with consecutive
bioenergetic failure [1,6], toxic action of cytokines
and disturbances in electrolyte gradients [1,3] may all
contribute. In addition, the inflammatory response also* Correspondence: werner.zgraggen@insel.ch
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article, unless otherwise stated.causes muscle catabolism and loss of muscle function
[7-11]. It has also been shown that resting membrane
potential is reduced [12].
Muscle fibres are complex electrical organs, in which
the accurate control of membrane potential, and the
interplay of multiple voltage-dependent ion channels,
have essential roles in normal physiological function.
Recently, a new protocol for clinical assessment of muscle
membranes has been devised. These muscle excitability
tests are based on the principle of assessing multi-fibre
velocity recovery cycles (VRCs). Using direct muscle
stimulation, a column of muscle fibres are excited with
paired stimuli separated by a variable inter-stimulus
interval. The conduction velocity of the second muscle
action potential of each pair changes as a function of the
inter-stimulus interval, allowing assessment of the
muscle relative refractory period (MRRP) and muscle
supernormality [13-19]. These two measurements are
sensitive to alterations in muscle membrane potential and
ion channel function, and in probable CIM muscle VRCtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Ackermann et al. Critical Care 2014, 18:484 Page 2 of 9
http://ccforum.com/content/18/4/484measurements indicate that muscle fibres are depolarized
and/or sodium channel inactivation is increased [20].
Up to now, muscle excitability measurements have only
been performed in patients diagnosed with probable CIM
according to the current guidelines [20]. Considering the
likely physiological mechanisms involved, we hypothesized
that muscle membrane dysfunction occurs early in sepsis.
To test this hypothesis, we studied muscle membrane
properties before and during the first 27 hours of
experimental sepsis induced by faecal peritonitis in pigs.
Materials and methods
The study was performed in accordance with the
National Institutes of Health guidelines for the care
and use of experimental animals and with the approval
(No. 100/08) of the ‘Animal Care Committee of the Canton
of Bern, Switzerland’. This study was an independent
sub-study in a trial of mechanical ventilation. Data on
mitochondrial function have been published separately [21].
Animal preparation
Twenty domestic pigs with an average weight of 40 ± 3 kg
(mean ± SD) were fasted overnight and intramuscularly
premedicated with ketamine-hydrochloride 100 mg,
azaperon 200 mg, and atropine 0.5 mg before induction of
anaesthesia and orotracheal intubation. The animals were
randomized into a non-septic control group and a faecal
peritonitis group (n = 10 in each group), and within
these groups to ventilation with either a time-cycled,
volume-controlled mode using a tidal volume of 6 to
8 ml/kg, a fraction of inspired oxygen of 0.4, and a
positive end-expiratory pressure of 5 cmH2O, or using
neurally adjusted ventilatory assist (Servo-i™, Maquet
Critical Care, Solna, Sweden) (n = 5 per group). In the
peritonitis group, 1 g/kg of autologous faeces dissolved in
200 ml glucose 5% was instilled into the abdominal cavity.
Anaesthesia was maintained throughout the experi-
ment with continuous intravenous infusions of ketamine-
hydrochloride (200 to 300 mg/h), midazolam (20 to
30 mg/h), and fentanyl (25 to 75 mcg/h). Neuromuscular
blocking agents were not used.
Mean arterial blood pressure (MAP) (Pressure Monitoring
Set, Edwards Lifesciences LLC, Irvine, CA, USA), cardiac
output, and mixed venous oxygen saturation (SvO2)
(Vigilance II, Edwards Lifesciences LLC, Irvine, CA,
USA) were monitored continuously.
A combination of lactated Ringer’s and glucose 50%
solutions were administered continuously throughout
the experiment at a combined total rate of 5 ml/kg h−1.
Glucose infusion was adjusted to maintain blood glucose
concentration between 3.5 and 6 mmol/l.
Additional fluid boluses and vasoactive drugs were
administered according to a haemodynamic protocol [21].
Briefly, a bolus of 50 to 100 ml Ringer’s lactate wasadministered when MAP was lower than 50 mmHg. The
procedure was repeated maximally twice per hour if MAP
remained <50 mmHg and if the first bolus had resulted in
an increase in stroke volume (measured by intermittent
thermodilution). If stroke volume did not increase, a con-
tinuous norepinephrine infusion was started and increased
to a maximum dose of 600 mcg/h.
Electrophysiological investigations
The following electrophysiological investigations were
performed: standard nerve conduction studies, needle
electromyography and muscle excitability measurements.
All studies were performed immediately before induction
of peritonitis as well as 6, 18 and 27 hours thereafter.
Conventional electrophysiological investigations
Motor nerve conduction studies were performed from
the ulnar nerve. The nerve was stimulated at the foreleg
distal from the elbow. Compound muscle action potentials
(CMAPs) were recorded from the interosseus dorsalis I
muscle using surface electrodes. Measured parameters
were: distal motor latency, CMAP amplitude, duration
and stimulus intensity for 50% maximal CMAP amplitude.
Concentric needle examinations were performed at
multiple insertion points from the extensor digitorum
muscle at the foreleg.
Muscle excitability measurements
Multi-fibre responses to direct muscle stimulation were
recorded from the foreleg using a recently described
protocol [15]. An insulated monopolar needle electrode
(TECA, VIASYS Healthcare, MI, Wisconsin, USA) was
used as cathode, and a non-polarizable surface electrode
as anode. The cathode was inserted into the extensor
digitorum muscle and the anode was positioned 15 mm
distal to the cathode. For stimulation, rectangular current
pulses of 0.05 ms duration were delivered by an isolated
linear bipolar current stimulator (DS5, Digitimer Ltd,
Welwyn Garden City, UK). Recordings were made with a
30G EMG electrode (Medtronic, Skovlunde, Denmark).
The EMG needle was inserted in the muscle about 15 to
25 mm proximal to the cathode. The signal was amplified
as described above. Stimulation and recording were
controlled by QTRAC software (written by H. Bostock,
copyright Institute of Neurology, London, UK). Multi-fibre
VRCs with single conditioning stimuli and with test stimuli
alone were recorded. Latency changes were measured as
conditioning stimuli were applied at inter-stimulus intervals
of 2 to 1000 ms (Figure 1). Data analysis has been described
in detail in previous articles [15,19]. The following VRC
parameters were assessed: (1) muscle relative refractory
period in ms (MRRP) and (2) early supernormality (ESN),
measured as the peak percentage reduction in latency at
inter-stimulus intervals shorter than 15 ms.
Figure 1 Recordings of multi-fibre action potentials in pig extensor digitorum at baseline (grey) and 27 hours after induction of sepsis
(black). (A) Recordings of multi-fibre action potentials in pig extensor digitorum at baseline (grey) and 27 hours after induction of sepsis (black).
Test stimulus is at latency 0 ms, and conditioning stimuli applied at intervals varied from 1,000 to 1.4 ms. Response latencies were measured to
peak after subtraction of response to conditioning stimulus alone. (B) Velocity recovery cycles at the two times plotted as percentage changes in
latency against the inter-stimulus interval (logarithmic scale).
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Blood samples including arterial blood gas analysis
were taken immediately after the electrophysiological
investigations. Sodium, potassium, glucose, lactate, pH,
bicarbonate, base excess and tumour necrosis factor alpha
(TNFα) were measured. Arterial blood samples were
analyzed in a blood gas analyzer (GEM 3000 analyzer,
Instrumentation Laboratory, Bedford, MA, USA), for
PaO2, PaCO2 (adjusted to central body temperature),
pH, lactate, bicarbonate, base excess (BE), sodium
and potassium. For SvO2 and haemoglobin, a device
calibrated for porcine blood was used (OSM 3, Radiometer,
Copenhagen, Denmark). Plasma TNFα was measured using
a porcine immunoassay kit (R&D Systems Europe Ltd,
Abingdon, UK).
Muscle morphology
Muscle biopsies were obtained at the end of the experiment
from all animals. Cross-sections (12 μm) were cut
perpendicular to the longitudinal axis of muscle fibres.
Haematoxylin and eosin and myofibrillar ATPase staining
was performed. In each animal, a cross-sectional area of
skeletal muscle fibres was measured from 50 muscle fibres
separately on one slice [22] by using light microscopy and
imaging software (NIH Image 1.62, National Institute of
Mental Health, Bethesda, MD, USA).
Densitometric scanning of immune reactive bands of
myosin normalized to actin
Densitometric scanning of immune reactive bands of
myosin protein normalized to actin was performed at the
end of the experiment. Skeletal muscle tissue sampleswere homogenized in ice-cold lysis buffer (250 mM
sucrose, 5 mM MgCl2, 50 mM Tris-HCl, pH 7.4) using a
glass pestle. The homogenates were then solubilized in
4X sodium dodecyl sulphate sample buffer containing
100 mM dithiothreitol, centrifuged for 5 min at 16,000 g
and the supernatants were collected. The protein con-
centration of the homogenates (supernatants) was de-
termined with the Quant-iTM assay kit and read with
the Qubit-TM fluorometer (Invitrogen, Life Technologies,
Zug, Switzerland).
Western blot analysis was performed using the
homogenates from all 10 control and 10 peritonitis
animals. Equal amounts of protein (10 μg per well)
were separated on NuPAGE 4 to 12% gradient gels
(Invitrogen, Life Technologies, Zug, Switzerland). Two
gels were used (one with 14 and one with 6 wells). Gels
were then transferred into nitrocellulose membranes with
the iBlot-TM dry blotting system (Invitrogen, Life
Technologies, Zug, Switzerland). Equal loading was
verified by staining the ex-gels with SimplyBlue™ SafeStain
(Invitrogen Life Technologies, Zug, Switzerland). After-
wards, the membrane was blocked for 30 min with the
incubation buffer (10 mM Tris-HCl, pH 7.5, 100 mM
NaCl and 0.1% w/v Tween 20) supplemented with 5%
bovine serum albumin. The membrane was then cut in
half and the lower half was incubated with the actin poly-
clonal antibody (dilution 1:1,000) (Sigma-Aldrich, Buchs,
Switzerland), whereas the upper half was incubated with a
rabbit skeletal muscle fast myosin heavy chain antibody
(Abcam, Cambridge, UK) (dilution 1:1,000) for 2 hours.
The membranes were then washed three times with incu-
bation buffer and incubated for 1 hour with horseradish
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(Ig)G (Novus Biologicals, Littleton, CO, USA) (dilution
1:1,000) secondary antibodies. Afterwards, the membranes
were developed with the enhanced chemiluminescence
detection kit (Thermo Scientific Pierce, Rockford, IL, USA).
The membranes were viewed in the ChemiDoc Gel
Documentation System (Bio-Rad Laboratories AG,
Reinach, Switzerland) for signal detection. Quantification
of protein bands (ECL signals) was performed by densi-
tometry using the Quantity One densitometry software
(Bio-Rad Laboratories AG, Reinach, Switzerland). The
sum of the myosin band pixel intensity (intensity x mm2)
in each lane was normalized to the corresponding actin
intensity (adjusted after local background subtractions for
each band) in the same lane.
Statistical analyses
Statistical analyses were performed using the QTRAC
data analysis software (copyright Institute of Neurology,
London, UK), which was also used to generate the
figures. Because the control and peritonitis groups differed
in variance, and because some of the measurements were
not normally distributed, differences between the control
and peritonitis group for the same time point were tested
by applying the Welch test to the ranked data. To
compare changes over time within the same treatment
group the Friedman test was used. Wilcoxon test was used
to compare values at baseline (defined as muscle excitability
measurements and blood samples taken immediately before
induction of peritonitis) with those at 27 hours. Proportions
were compared using the Fisher’s exact test (GraphPad
InStat 3.05; GraphPad, San Diego, CA, USA). To compareTable 1 Laboratory characteristics of control animals and ani
Controls (n = 10) Wilco
Baseline 27 hours (P va
Weight (kg) 39.1 ± 3.7
Core temperature (°C) 38.50 ± 0.65 40.59 ± 0.34 0.0039
Mean arterial pressure (mmHg) 76.0 ± 14.3 88.6 ± 12.7 0.002*
Heart rate (bpm) 80.1 ± 16.6 82.9 ± 20.7 0.82
Cardiac output (l/min) 5.0 ± 1.3 4.6 ± 0.6 0.50
Stroke volume 63.2 ± 9.3 57.7 ± 10.1 0.65
Sodium (mmol/l) 135.5 ± 1.9 141.5 ± 2.4 0.004*
Potassium (mmol/l) 4.0 ± 0.4 4.1 ± 0.2 0.61
Glucose (mmol/l) 8.4 ± 1.3 5.4 ± 0.4 0.002*
Lactate (mmol/l) 1.2 ± 1.1 1.1 ± 0.4 0.77
pH 7.52 ± 0.04 7.47 ± 0.02 0.002*
Bicarbonate (mmol/l) 32.6 ± 1.8 31.4 ± 3.0 0.27
Base excess (mmol/l) 9.1 ± 2.7 7.9 ± 2.8 0.39
TNFα (pg/ml) 86.6 ± 76.2 60.9 ± 22.7 0.30
Wilcoxon test was used for comparison of baseline and 27-hour measurements with
measurements between controls and animals with peritonitis. (* = P <0.05, ** = P <0fibre size and values of densitometric scanning of immune
reactive bands of myosin protein normalized to actin
between the control and peritonitis group, unpaired
Student’s t test was used. A P value of <0.05 was considered
statistically significant. Data are given as mean ± SD.
There is a known significant dependency of MRRP mea-
surements on body muscle temperature, which varied from
36.3 to 39.8°C in the control pigs and from 33.8°C to 39.7°C
in the peritonitis group [23]. Because of this sensitivity of
MRRP, all the MRRP values were corrected to the mean
control temperature of 37.9°C before making statistical
comparisons, using the relationship for the 40 control
recordings (MRRP = 12.0 - 0.253.T; Pearson R = −0.54,
P = 0.00057)). In contrast to the high sensitivity of MRRP
to temperature, ESN is relatively insensitive to temperature
changes (R = 0.225, P = 0.17) as found previously [23].
Results
Characteristics of controls and animals with peritonitis
at baseline and 27 hours thereafter, including weight,
core temperature, systemic haemodynamics and laboratory
measurements are summarized in Table 1. In septic pigs,
there was a progressive increase of heart rate and decrease
of stroke volume, whereas these parameters remained
unchanged in controls over time (Figure 2). Septic
pigs had lower blood pressure and markedly increased
TNFα, higher lactate and lower pH and bicarbonate
as compared to controls. Septic pigs received more
fluids (7,150 ± 770 ml compared to 630 ± 550 ml in
controls, P <0.01). Seven of ten peritonitic animals
but none of the controls received norepinephrine to
support the haemodynamics (P = 0.0031).mals with peritonitis (values are given as mean ± SD)
xon Peritonitis (n = 10) Wilcoxon Welch rank
lue) Baseline 27 hours (P value) (P value)
40.2 ± 2.3
** 38.16 ± 0.76 40.77 ± 0.37 0.002** 0.39
* 78.6 ± 12.5 66.5 ± 19.9 0.16 0.009**
68.5 ± 12.2 143.9 ± 25.4 0.002** 0.00009****
4.5 ± 0.9 4.8 ± 1.2 0.84 0.92
65.9 ± 7.1 39.1 ± 13.7 0.004** 0.0011**
* 134.3 ± 2.5 131.4 ± 2.6 0.19 0.00008****
4.0 ± 0.2 4.1 ± 0.4 0.76 0.76
* 9.4 ± 1.3 5.0 ± 1.0 0.002** 0.21
1.0 ± 0.6 1.8 ± 0.7 0.05* 0.016*
* 7.51 ± 0.04 7.41 ± 0.06 0.004** 0.010*
32.2 ± 1.5 26.9 ± 2.8 0.004** 0.004**
9.3 ± 1.9 2.5 ± 3.6 0.006** 0.006**
69.6 ± 46.9 317.6 ± 187.8 0.006** 0.002**
in each group. Welch test of ranked data was used to compare 27-hour
.01, **** = P <0.0001). TNFα, tumour necrosis factor alpha.
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Figure 2 Differences between control animals (white) and
animals with peritonitis (black) at baseline, 6 hours, 18 hours
and 27 hours after induction of sepsis. (A) Heart rate, (B) stroke
volume. Boxes indicate interquartile ranges and lines indicate
median values. Comparisons between control and peritonitis
animals were made with Welch rank test (NS = P >0.05, * = P <0.05,
** = P <0.01, **** = P <0.0001).
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Results of motor nerve conduction studies are shown
in Table 2 and Figure 3. In the peritonitis group,
there was a significant increase of CMAP duration
and stimulus intensity for 50% maximal CMAP at 27
hours, whereas both parameters remained unchanged
in controls. None of the animals showed abnormalities
(fibrillation potentials or positive sharp waves) in needle
electromyography.
Muscle velocity recovery cycles
Mean muscle VRCs for controls and animals with periton-
itis are shown in Figure 4. Before peritonitis induction,
mean muscle VRCs of both groups overlapped. After
induction of peritonitis, VRCs of animals with peritonitisTable 2 Nerve and muscle properties of controls and pigs wit
Controls (n = 10) W
Baseline 27 hours (P
Nerve conduction studies
CMAP amplitude (mV) 1.62 ± 1.22 1.55 ± 1.08 0
CMAP duration (ms) 1.25 ± 0.11 1.40 ± 0.18 0
Stimulus for 50% maximal CMAP (mA) 3.74 ± 1.92 4.16 ± 2.04 0
Muscle velocity recovery cycles
Muscle relative refractory period (ms) 2.41 ± 0.42 2.44 ± 0.46 0
Early supernormality (%) 8.28 ± 2.69 8.64 ± 1.96 0
(* = P <0.05, ** = P <0.01). CMAP, compound muscle action potential.were shifted progressively to the right and upwards. In
contrast, VRCs of controls did not change over time.
The shift to the right corresponds to a significant increase
in MRRP in the peritonitis group, and a significant
difference compared to the control group at 27 hours
(Figure 5A, Table 2). Similarly, the shift upwards corre-
sponds to a significant reduction in ESN in the peritonitis
group, and a significant difference compared to the
controls at 27 hours (Figure 5B, Table 2).
The differences between the control and peritonitis
groups in MRRP and ESN developed early (Figure 5).
Whereas baseline values of MRRP did not differ between
groups, MRRP became progressively longer in the
peritonitis group and was significantly different compared
to controls 18 and 27 hours after induction of peritonitis
(P ≤0.006) (Figure 5A).
ESN also did not differ between the groups at baseline,
but was significantly reduced at 6, 18 and 27 hours
(P ≤0.027) (Figure 5B).
Muscle morphology and densitometric scanning of
immune reactive bands of myosin normalized to actin
Mean cross-sectional area of skeletal muscle fibres was
1,490 ± 320 μm2 in the control and 1,450 ± 160 μm2 in the
peritonitis group (P >0.05). Mean values of densitometric
scanning of immune reactive bands of myosin normalized
to actin were 0.26 ± 0.27 in the control and 0.13 ± 0.09 in
the peritonitis group. This difference was not statistically
significant (P >0.05). An additional file shows a represen-
tative skeletal muscle Western blot analysis and differences
in densitometric scanning of immune reactive bands of
myosin protein normalized to actin between control
animals and animals with peritonitis (see Additional file 1).
Discussion
Various studies have shown that muscle excitability
measurements allow in vivo assessment of muscle
membrane properties [15-19]. We have previously
used this technique in critically ill patients diagnosed
with probable CIM [20]. In the current study, muscleh peritonitis (values are given as mean ± SD)
ilcoxon Peritonitis (n = 10) Wilcoxon Welch rank
value) Baseline 27 hours (P value) (P value)
.19 1.05 ± 0.94 1.20 ± 1.17 0.19 0.80
.064 1.33 ± 0.14 1.61 ± 0.27 0.020* 0.044*
.77 3.32 ± 1.12 4.79 ± 1.51 0.0020** 0.35
.63 2.38 ± 0.18 3.47 ± 1.79 0.0098** 0.0048**
.63 9.64 ± 2.82 6.50 ± 2.64 0.0039** 0.0061**
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Figure 3 Differences between control animals (white) and animals
with peritonitis (black) at baseline, 6 hours, 18 hours and 27 hours
after induction of sepsis. (A) CMAP duration, (B) stimulus intensity to
evoke an amplitude of 50% maximal CMAP. Boxes indicate interquartile
ranges and lines indicate median values. Comparisons between control
and peritonitis animals were made with Welch rank test (NS = P >0.05,
* = P <0.05). CMAP, compound muscle action potential.
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the early course of experimental peritonitis-induced
sepsis in a pig model. The latter might be more suitable for
studying sepsis-associated changes than rodent models
[24]. Our results show that muscle membrane dysfunction
occurred as early as 6 hours after induction of faecal
peritonitis in pigs. There was a progressive reduction of
ESN and prolongation of MRRP in the peritonitis group
over 27 hours compared to controls. In parallel, conven-
tional electrophysiology revealed an increased duration of
CMAPs and an increase of stimulus threshold in peritonitis
animals 27 hours after peritonitis induction.Figure 4 Mean muscle velocity recovery cycles for the 10 control anima
peritonitis (filled black circles) at (A) baseline, (B) 6 hours, (C) 18 hours aSimilar changes of muscle membrane properties have
already been shown in critically ill patients diagnosed
with probable CIM [20], during ischaemia [15,17] and in
patients with chronic renal failure [16]. In probable
CIM, we found a significant relationship between mem-
brane dysfunction (that is fall in ESN and rise in MRRP)
and potassium. Compared to patients with chronic renal
failure, this relationship was much steeper in patients with
probable CIM, suggesting that additional factors besides
the expected dependence of membrane properties on
potassium were involved [16,20]. The changes in our earl-
ier studies during ischaemia were interpreted as a result of
membrane depolarization, which was assumed to occur in
ischaemia following ATP depletion and, therefore, failing
of the Na+/K+ pump [15]. Ischaemia or tissue hypoxia due
to inadequate tissue perfusion is likely to be also involved
in sepsis. Furthermore, the changes in ESN and MRRP do
not necessarily indicate membrane depolarization alone,
since they can also occur because of increased sodium
channel inactivation or reduced sodium channel availability
[20]. In fact, earlier studies have demonstrated a selective
inactivation of muscle sodium (Nav1.4) channels in CIM
and reduced channel availability in a potential-dependent
fashion [25-27].
Currently, the pathophysiology of sepsis-associated
multiple organ failure, of which sepsis-induced myopathy
and CIM may represent muscle manifestations, remains a
matter of debate, and several mechanisms may be involved.
Cell membrane potential changes have been observed in
several experimental models, and proposed to be a pivotal
mechanism for sepsis-related cellular dysfunction [28-32].
The evolution of cellular membrane potential changes dur-
ing clinical sepsis has not been studied. Our results confirm
the earlier reports on early muscle membrane potential
changes in ICU patients obtained with invasive measure-
ments [12]. Although, at the time the aforementioned study
was carried out the entity of CIM was not yet described for
the first time, the enrolled patient cohort very likelyls (open grey circles) compared with those for the 10 animals with
nd (D) 27 hours after peritonitis induction. Error bars indicate SEM.
510 NS
*
**
**
Baseline 6h 18h 27h
2
3
4
NS
NS
**
**
A
M
us
cl
e 
re
la
tiv
e 
re
fra
ct
or
y 
pe
rio
d 
(m
s)
Ea
rly
 s
up
er
no
rm
al
ity
 
(m
s)
B
Figure 5 Differences between control animals (white) and
animals with peritonitis (black) at baseline, 6 hours, 18 hours
and 27 hours after induction of sepsis. (A) Muscle relative
refractory period, (B) early supernormality. Boxes indicate
interquartile ranges and lines indicate median values. Comparisons
between control and peritonitis animals were made with Welch rank
test (NS = P >0.05, * = P <0.05, ** = P <0.01).
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other study invasively measured muscle membrane poten-
tial in ICU patients because of the potential risks. Muscle
VRC measurements provide a clinically feasible approach
to study changes in muscle cell membrane properties non-
invasively. As already mentioned, there is evidence that the
toxic action of cytokines, anoxia or disturbances in the elec-
trolyte gradients influence the resting membrane potential,
provoking muscle membrane dysfunction [1,3,6]. Altered
mitochondrial function has been proposed to contribute
[33]. Nevertheless, in our animal model, faecal peritonitis
had no measurable effects on skeletal muscle mitochondrial
respiration [21]. All of the above-mentioned mechanisms
could contribute to membrane dysfunction early in the
course of sepsis-induced myopathy and/or CIM. Membrane
dysfunction may act as the common mechanism for struc-
tural changes [5,6,8,9] in the course of disease.
Our study has some limitations. First, it was not
possible to blind the investigators with respect to the
different experimental groups. This is unlikely to
cause bias, since we used well-defined treatment and
recording protocols for all animals. Second, amount of
fluid and therefore also sodium, as well as norepinephrine
administration was higher and plasma sodium lower in
the peritonitis group. We found no association between
plasma sodium and excitability measurements in this
study and earlier studies using the same methods
[20]. We therefore believe that these differences are
unlikely to explain the observed changes in sepsis. Ina recent clinical observational study, the required amount
of catecholamine was found to be a risk factor for the
development of impaired direct muscle stimulation in a
univariate but not in a multivariate Cox regression
analysis [34]. We can relate our findings to sepsis-induced
myopathy but not to CIM, since the observation period
was too short and we did not find the morphometric
changes of muscle fibres characteristic of CIM, and also
there was no significant change of mean values of densito-
metric scanning of immune reactive bands of myosin nor-
malized to actin. These findings are in line with reported
data of studies using other animal models for CIM over a
longer observational period if the findings within the first
day are compared [35,36]. Another limitation is the use of
two different mechanical ventilation modes. The pigs were
randomly allocated in the mode of ventilation, and we stud-
ied peripheral muscles, not respiratory muscles, and found
no differences in excitability parameters depending on the
ventilatory mode. Overall, application of results from ex-
perimental sepsis in animal models to clinical sepsis must
be done with caution.
Conclusions
In summary, it seems likely that changes in muscle
membrane properties provide an early indication of the
development of CIM, although the underlying mecha-
nisms are not completely understood. Muscle VRCs are
a practicable tool for monitoring muscle membrane
changes and may lead to earlier diagnosis of CIM in the
future, and can facilitate further studies investigating the
pathophysiology and prevention of this disease.
Key messages
 Muscle VRCs can be used to assess changes of
muscle membrane properties.
 In CIM, the muscle relative refractory period is
prolonged and early supernormality reduced.
 Changes to muscle membrane properties occur early
in the course of sepsis.
Additional file
Additional file 1: Densitometric scanning of immune reactive bands
of myosin normalized to actin. Figure of representative skeletal muscle
Western blot analysis and differences in densitometric scanning of
immune reactive bands of myosin protein normalized to actin between
control animals and animals with peritonitis.
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